Detection, treatment, and care of individuals with TB continue to be a challenge, particularly in settings with a high burden of disease and weakened healthcare infrastructure. More recently, the COVID-19 pandemic has added complex layers of stress to health systems worldwide, hampering progress in the fight against TB. The Global Laboratory Initiative (GLI) and the Global Drug-Resistant TB Initiative (GDI) are working towards strengthening laboratory and clinical management capacity for the programmatic management of TB.
Through this workshop participants will be able to:
- Explore the challenges encountered in countries
- Steer the discussion on how to address these as protect progress in the fight against TB
Session sponsor: World Health Organization
Chairs: Dr. Marguerite Massinga, Africa CDC and ASLM and Dr. Sarabjit Chadha, The Foundation For Innovative New Diagnostics
Coordinators: Medea Gegia, WHO and Carl Nathanson, WHO
Target audience: NTP managers, Laboratory specialists, TB clinicians, Nurses, Community health care workers.
Recorded on Tuesday, 22nd November 2022
